NNNN Short Volume
Anbio Biotechnology Class A Ordinary Shares (NNNN) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $400.3M, listed on NASDAQ, employing roughly 27 people, carrying a beta of 5.10 to the broader market. Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. Led by Michael Lau, public since 2025-02-19.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-07-16
- Short Volume
- 5.7K
- Total Volume
- 10.9K
- Short %
- 52.03%
- 30-Day Avg Short %
- 46.48%
Showing 30 days of FINRA short volume data for Anbio Biotechnology Class A Ordinary Shares.
Learn how short volume is reported and how to read the data →
Frequently asked NNNN short volume questions
- What is the daily NNNN short volume?
- As of Jul 16, 2026, Anbio Biotechnology Class A Ordinary Shares (NNNN) short volume is 5.7K shares against 10.9K total reported volume, or 52.03% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is NNNN short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does NNNN short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.